Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.
Medicare GLP-1 Bridge $50 Copay: What You Actually Pay in 2026
Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
The 10-second answer
| Question | Answer |
|---|---|
| Is it real? | Yes, for eligible Part D members. |
| Starts | July 1, 2026 |
| Ends | December 31, 2027 |
| Cost | $50 per monthly supply — it doesn't rise with your dose |
| Covered | Foundayo, all Wegovy forms, Zepbound KwikPen only |
| Not covered | Ozempic, Mounjaro, Rybelsus, compounded GLP-1s, Zepbound vial/single-dose pen |
| Counts toward your Part D cap? | No |
| Does Extra Help lower it? | No |
Sorts you into Bridge, regular Part D, or fallback — with your next step. Free, no email.
Yes — the Medicare GLP-1 Bridge $50 copay is real, but it’s a special government program, not regular Medicare coverage, and the $50 is not automatic. Starting July 1, 2026, eligible Medicare Part D members can get certain FDA-approved weight-loss GLP-1s for $50 per monthly supply, through a short-term program that runs through December 31, 2027.
The number that surprises people isn’t the $50. It’s that the $50 stays $50 — every month, even as your dose climbs and the cash price keeps rising. (Zepbound’s KwikPen runs up to $699 a month at the cash price.) That one rule is where the real money lives — and it’s also where most articles quietly get the details wrong.
So before you call your plan, switch your prescription, or assume you’ve missed your shot — give us two minutes. We’ll show you exactly what the $50 covers, the one catch that trips people up, and the words that get your pharmacy claim to actually go through.
Is the Medicare GLP-1 Bridge $50 copay real, or another too-good-to-be-true headline?
For years, the law blocked Medicare from paying for drugs used only for weight loss. That’s why so many older Americans have been paying cash — often hundreds a month. The Bridge is the government’s short-term workaround while a bigger, permanent plan gets sorted out.
It's posted on CMS's own website, with an official launch date of July 1, 2026.
CMS has already published the pharmacy billing codes (shared below — they're how your claim gets paid).
A senior HHS official, Chris Klomp, Director of Medicare, called it a program "designed to make accessing those medications simpler, more predictable, and more consistent."
Don’t misread the headline: “$50 GLP-1s for Medicare” does not mean every person on Medicare can get any GLP-1 for $50. The drug, the form, the reason it’s prescribed, and your plan type all have to line up. Miss one and the price won’t be $50 — it’ll be the full cash price. That’s the trap this page exists to keep you out of.
See where you land in 60 seconds. Free, no email.
Who actually gets the $50 — and who doesn’t
CMS also requires that the medicine is prescribed to help you lose excess weight and keep it off, alongside ongoing lifestyle changes — structured nutrition and physical activity — in line with the drug’s FDA-approved label.
The three exact clinical routes to the $50
This is the part news articles oversimplify — and getting it wrong wastes a doctor’s visit. CMS uses three exact routes. Your prescriber attests that you’re 18 or older and that, at the time you started GLP-1 therapy, you met one of these:
| Your BMI when you started the medicine | What else is required |
|---|---|
| 35 or higher | Nothing else — BMI alone qualifies. |
| 30 or higher | Plus one of: heart failure with preserved ejection fraction (HFpEF); uncontrolled high blood pressure (above 140/90 despite two blood-pressure medicines); or chronic kidney disease stage 3a or higher. |
| 27 or higher | Plus one of: prediabetes; a previous heart attack; a previous stroke; or symptomatic peripheral artery disease (PAD — reduced blood flow in the limbs). |
Two things people miss:
- →It’s your BMI when you started the drug, not today. If you started in 2024 at a BMI of 37 and you’re at 34 now, your prescriber attests you met the “BMI 35+” route at the time you started. Losing weight on the drug doesn’t disqualify you.
- →High blood pressure and kidney disease are in the BMI 30+ route, not the 27+ route. Don’t assume a single condition plus a BMI of 27 qualifies — match the route exactly.
Every BMI route, every qualifying condition, every plan type — in one place.
Which Medicare plan types qualify — and which don’t?
Most people with Medicare drug coverage are plan-eligible, but there are real exceptions. CMS confirms these plan types qualify:
- Standalone Part D plans (PDP)
- Medicare Advantage drug plans (HMO, HMO-POS, and local/regional PPO)
- Special Needs Plans
- Employer/union group plans
- LI NET program
- Dual-eligible members (Medicare + Medicaid) in eligible plan types
These plan types are not eligible on their own (unless you’re also enrolled in a standalone Part D plan): private fee-for-service plans, section 1876 cost contract plans, section 1833 health care prepayment plans, PACE organizations, fallback plans, and religious fraternal benefit plans.
Two groups should not assume they qualify for the $50:
- 1.People taking a GLP-1 for diabetes, heart-risk reduction, or sleep apnea. That’s a different lane. The Bridge is for weight management only.
- 2.People on compounded GLP-1s. Compounded versions are not allowed through the Bridge.
Check your path before your doctor visit — so you walk in knowing exactly what to ask.
Which drugs and forms get the $50 (and the one that trips everyone up)
| Drug | Form | Bridge status | Common mistake |
|---|---|---|---|
| Foundayo | All forms (pill) | ✅ Covered | — |
| Wegovy (semaglutide) | Injection and tablet | ✅ Covered | — |
| Zepbound (tirzepatide) | KwikPen only | ✅ Covered | Prescription written for a vial or single-dose pen instead of the KwikPen |
| Zepbound | Single-dose vial / single-dose pen | ❌ Not covered | Assuming “Zepbound is Zepbound” |
| Ozempic, Mounjaro, Rybelsus | Any | ❌ Not a Bridge weight-loss drug | Assuming diabetes GLP-1s are on the weight-loss list |
| Compounded semaglutide/tirzepatide | Any | ❌ Not allowed | Assuming a cash compound can become a $50 Bridge claim |
Zepbound is only covered as the KwikPen. A Zepbound vial or single-dose pen won’t process as a $50 Bridge claim — even though it’s the same medicine. If you’re on Zepbound, ask your prescriber whether the Zepbound KwikPen is the right form for you before the prescription is sent.
See which path fits your drug before you talk to your doctor.
Does the Medicare GLP-1 Bridge $50 copay count toward Part D? The catch nobody puts in the headline
If you get Extra Help (the low-income program that lowers drug costs), that subsidy does not apply to Bridge claims. You pay $50, regardless. Read that twice if you have Extra Help. For some lower-income members, a flat $50 could actually be more than what you’d normally pay with your subsidy. If that’s you, check your specific numbers with your plan first.
The reframe: The Bridge is not regular Part D coverage with a $50 copay. If reaching your out-of-pocket cap on other expensive drugs is your top priority, regular Part D for a qualifying condition might serve you better. But for the typical person paying cash today, the Bridge does something hard to beat: a predictable $50 per monthly supply that doesn’t climb when your dose climbs.
$50 flat vs. paying cash — the comparison that actually matters
Cash prices for these drugs go up as your dose goes up — and most people need a higher dose over time to keep weight off. The Bridge copay doesn’t move. The cash figures below are TrumpRx / direct-to-consumer prices reported by KFF Health News; actual cash offers can change by drug, dose, refill rules, and date.
| Drug & form | Reported cash price (climbs with dose) | Your Bridge copay | Gap at high dose |
|---|---|---|---|
| Wegovy injection | $199 → $399/mo | $50 | ~$349/mo |
| Wegovy pill | up to $299/mo | $50 | ~$249/mo |
| Zepbound KwikPen | up to $699/mo | $50 | ~$649/mo |
| Foundayo | up to $349/mo | $50 | ~$299/mo |
Cash-price source: KFF Health News reporting on TrumpRx / direct-to-consumer prices, verified May 28, 2026. Re-check on publish day, because cash offers can change.
Look at the Zepbound line. At a maintenance dose, that’s the difference between $50 and $699 for the same box — every month. Over a year, that’s the gap between about $600 and more than $8,000. The Bridge’s real power isn’t the low number — it’s that the number is locked.
Compare your options in 60 seconds — shows the cheaper lane for your exact drug and plan.
Bridge or regular Part D? Same drug, different lane
Wegovy for weight loss, and you meet the CMS criteria
Bridge ($50)
Wegovy to lower heart-attack/stroke risk in people with heart disease
Regular Part D (your plan's normal cost)
Zepbound KwikPen for weight loss, and you meet the CMS criteria
Bridge ($50)
Zepbound for obstructive sleep apnea
Regular Part D
The most useful question you can ask your prescriber:
“Is this prescription being written for Bridge-eligible weight management, or for a regular Part D condition like diabetes, heart-risk reduction, or sleep apnea?”
That one sentence prevents the most common mix-up — and it tells your doctor’s office you already know how this works.
How the doctor and pharmacy process really works (no application form)
The program launches July 1, 2026
Treat July 1 as the starting line. What you can do now: make sure your doctor has your BMI (at the time you started therapy) and your qualifying condition documented.
Your doctor doesn't need to be 'enrolled in Medicare'
They just can't be on Medicare's preclusion list — a list of barred providers.
Your pharmacy doesn't need to 'opt in'
Pharmacies just submit the Bridge claim electronically. Paper claims and mail-in reimbursement are not accepted.
Your pharmacy routing card (worth printing)
If your pharmacist says “this isn’t covered,” the first thing to check is whether the claim went through your normal Part D plan instead of the Bridge. These are the exact codes CMS published on its official payer sheet. Hand them over:
| Field | What to give the pharmacy |
|---|---|
| Plan / Group | GLP1Bridge |
| BIN | 028918 |
| PCN | MEDDGLP1BR |
| Processor | SS&C Health (routed through RelayHealth) |
| Cardholder ID | Your Medicare number (the MBI on your red-white-and-blue card) |
| Help desk | 844-673-0910 |
| Effective | July 1, 2026 |
The words to say at the counter: “Please run this through the CMS GLP-1 Bridge — BIN 028918, PCN MEDDGLP1BR — not my Part D plan.”
Bring it to your visit and turn a confusing conversation into a 5-minute confirmation. Free, no email.
When the price isn’t $50: a quick troubleshooting table
Almost every Bridge problem comes from a mismatch — wrong drug form, wrong lane, wrong billing route, or wrong plan type. Here’s how to spot it fast instead of spending an afternoon on hold.
| What went wrong | What it probably means | What to say |
|---|---|---|
| Pharmacy says "not covered" | Claim was routed through your regular Part D plan | "Please run it on the Bridge — BIN 028918, PCN MEDDGLP1BR." |
| Copay came out higher than $50 | Wrong drug form, wrong lane, or wrong route | "Is this going through the Bridge or my Part D plan?" |
| Doctor says "Medicare doesn't cover weight-loss drugs" | They're thinking of normal Part D, not the Bridge | "I mean the CMS GLP-1 Bridge demonstration. Can your office submit the Bridge prior authorization?" |
| You have Extra Help but still owe $50 | Extra Help doesn't apply to the Bridge | "Is this the Bridge copay? Would regular Part D be cheaper for my situation?" |
| Zepbound claim rejected | It was written as a vial/single-dose pen | "Would the Zepbound KwikPen be appropriate for me?" |
| You're on a compounded GLP-1 | Compounds aren't allowed on the Bridge | "Can I switch to an FDA-approved Bridge drug?" |
The questions real Medicare members are asking right now
The Bridge launches in summer 2026, so there are no patient results to share yet — and we won’t invent any. But the confusion is already everywhere in public Medicare forums. Here’s what people keep asking, and the short answers:
"So I just pay $50 and nothing else, for any dose of Zepbound?"
Yes, the copay is a flat $50 per monthly supply regardless of dose — if it's the KwikPen, prescribed for weight loss, and you're eligible.
"What does 'meet the criteria' actually mean?"
A Part D plan, plus one of the three BMI routes above, attested by your prescriber. Full breakdown on our eligibility guide.
"Does this work with Medicare Advantage, or only standalone drug plans?"
Both, as long as your Advantage plan includes drug coverage (MA-PD) and is an eligible plan type.
"Does the $50 count toward my Part D cap?"
No. That's the catch we covered above. The Bridge runs outside your normal Part D benefit.
If the $50 Bridge doesn’t fit you — or you can’t wait until July 1
Your drug is for diabetes, heart-risk, or sleep apnea
That's likely a regular Part D path. Talk to your prescriber and your plan, or a free Medicare counselor (SHIP).
You're on a compounded GLP-1 or a non-covered form
Ask your prescriber whether a covered Bridge drug is right for you — never switch for price alone.
You simply can't wait until July 1, 2026
There are FDA-approved, pay-as-you-go telehealth options that can get you started now. See the option below.
Sponsored option — this is NOT the Medicare Bridge
Ro Body (sponsored affiliate link, opens in a new tab) is a cash-pay telehealth platform that carries FDA-approved GLP-1s including Zepbound and Foundayo. Because Ro is cash-pay, it does not use your Medicare or Part D benefit and cannot get you the Bridge’s $50 price. This is a fallback for when the Bridge isn’t an option yet.
Get started for $39, then $149/month — or as low as $74/month with an annual plan paid upfront. Medication billed separately. If you qualify for the Bridge, it will almost certainly cost you less than any cash-pay program — check that path with your prescriber first.
See Ro’s current cash-pay pricing → (sponsored affiliate link, opens in a new tab)Disclosure: The RX Index may earn a commission. Ro is a cash-pay path and is not a Medicare GLP-1 Bridge application path.
Free 60-second matching quiz — Bridge, regular Part D, or cash-pay, with your next step spelled out.
What we actually verified for this guide
We don’t ask you to take our word for it. Here’s what we checked, and where:
| What we verified | Source | Last checked |
|---|---|---|
| Program dates (Jul 1, 2026 – Dec 31, 2027) | CMS Medicare GLP-1 Bridge FAQ | ✓ May 28, 2026 |
| $50 per monthly supply; doesn't rise by benefit phase | CMS Medicare GLP-1 Bridge FAQ | ✓ May 28, 2026 |
| Covered drugs & the KwikPen-only rule | CMS Medicare GLP-1 Bridge FAQ | ✓ May 28, 2026 |
| Three BMI/condition clinical routes | CMS Medicare GLP-1 Bridge FAQ | ✓ May 28, 2026 |
| Eligible plan types + excluded plan types | CMS Medicare GLP-1 Bridge FAQ | ✓ May 28, 2026 |
| $50 doesn't count toward TrOOP/Part D cap; Extra Help & coupons don't apply | CMS Medicare GLP-1 Bridge FAQ | ✓ May 28, 2026 |
| Deductible/cap and cash-price context | KFF Health News | ✓ May 28, 2026 |
| Pharmacy BIN/PCN, processor, help desk | CMS GLP-1 Bridge payer sheet | ✓ May 28, 2026 |
| Reported TrumpRx cash prices | KFF Health News | ⚠ Re-verify on publish day |
| Ro membership pricing | Ro | ⚠ Re-verify on publish day |
What this page does not do: it doesn’t decide your eligibility, submit your prior authorization, or replace your doctor, your plan, your pharmacist, or CMS. It gets you ready to walk in informed — and to make sure the claim runs through the Bridge so you’re paying the $50 copay, not the cash price.
Frequently asked questions
Is the Medicare GLP-1 Bridge really $50?
Yes. CMS says eligible Part D members can get certain weight-loss GLP-1s for $50 per monthly supply through the Bridge, from July 1, 2026 through December 31, 2027.
Is the $50 automatic for everyone on Medicare?
No. You need eligible Part D drug coverage, a covered drug in a covered form, a weight-management prescription, and you must meet one of CMS's three BMI-and-condition routes.
Who qualifies for the Medicare GLP-1 Bridge — what are the BMI rules?
CMS uses three routes, based on your BMI when you started the medicine: BMI 35 or higher alone; BMI 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a or higher; or BMI 27 or higher with prediabetes, a prior heart attack, a prior stroke, or symptomatic peripheral artery disease.
Which Medicare plans are eligible for the GLP-1 Bridge?
Standalone Part D plans, Medicare Advantage drug plans (HMO, HMO-POS, local or regional PPO), Special Needs Plans, employer or union group plans, LI NET, and dual-eligible members in those plan types. Private fee-for-service, section 1876 cost, section 1833 prepayment, PACE, fallback, and religious fraternal benefit plans are not eligible unless the person also has a standalone Part D plan.
Does the $50 count toward my Part D out-of-pocket cap?
No. The Bridge runs outside normal Part D, so the $50 does not count toward your deductible or the yearly out-of-pocket cap ($2,100 in 2026, $2,400 in 2027).
Does Extra Help lower the $50 copay?
No. Low-income Extra Help subsidies do not apply to the Bridge copay. If you have Extra Help, compare your normal cost with your plan first.
Can I use a manufacturer coupon or savings card to get below $50?
No. CMS says coupons and discount programs cannot be applied to Bridge claims.
Which drugs are covered by the Medicare GLP-1 Bridge?
Foundayo (all forms), Wegovy (injection and tablet), and Zepbound KwikPen only. Ozempic, Mounjaro, Rybelsus, the Zepbound vial and single-dose pen, and compounded GLP-1s are not covered.
Is Ozempic or Mounjaro included?
Not as Bridge weight-loss drugs. They may be covered by regular Part D for type 2 diabetes — a separate lane with separate rules.
Is the Zepbound vial covered?
No — only the Zepbound KwikPen. If you're on vials, ask your prescriber whether the KwikPen is appropriate for you before the prescription is written.
Are compounded GLP-1s covered?
No. Compounded versions are not allowed through the Bridge. Only the specific FDA-approved products and NDCs CMS lists are covered.
Do I need Humana insurance to use the Bridge?
No. Humana runs the central processing on behalf of CMS, but you do not need a Humana plan to use the Bridge.
How do I apply for the Medicare GLP-1 Bridge?
There's no patient form. Your prescriber submits a prior authorization and prescription to the CMS central processor starting July 1, 2026. You fill it at a pharmacy that collects the $50. See our full application-process guide for the complete walkthrough.
What happens after December 31, 2027?
The Bridge is scheduled to end on December 31, 2027. Do not assume the $50 path continues unless CMS extends or replaces it.
What should I bring to my doctor?
Your Part D or MA-PD card, your BMI history (including when you started the medicine), your diagnoses, your medication list, and one question: Is this a Bridge-eligible weight-management prescription, or a regular Part D condition?
Free 60-second matching quiz — Bridge, Part D, or fallback, with your next step spelled out.
Sources
- CMS — Medicare GLP-1 Bridge FAQ (dates, $50 copay, covered drugs/forms, three clinical routes, eligible and excluded plan types, Humana central processor, coupons/Extra Help/TrOOP, indication lanes)
- CMS — GLP-1 Bridge Payer Sheet (Plan/Group GLP1Bridge, BIN 028918, PCN MEDDGLP1BR, SS&C Health via RelayHealth, help desk 844-673-0910, effective July 1, 2026)
- KFF — What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge
- KFF Health News — A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know (TrumpRx cash prices; deductible and cap context)
Related guides: Medicare GLP-1 Bridge eligibility · How to apply for the Bridge · What the $245 net price means · Does Medicare cover Wegovy? · Does Medicare cover Zepbound?
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We are not affiliated with CMS, Medicare, Humana, Novo Nordisk, or Eli Lilly. This page is general information, not medical, legal, or financial advice. Confirm your specifics with your prescriber, your plan, and CMS. Some links are sponsored, which may earn us a commission at no extra cost to you; this does not affect the facts above or our editorial conclusions. . Next re-verification: monthly until the July 1, 2026 launch, then quarterly.